amifostine anhydrous has been researched along with glutamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bubrick, MP; Carroll, MP; Feeney, DA; Johnston, GR; Roberts, JC; Schlafmann, SE; West, MA; Zera, RT | 1 |
| Mazeron, JJ; Noël, G | 1 |
| Hogle, WP | 1 |
| Bowen, JM; Keefe, DM; Sonis, ST | 1 |
| Rosenthal, DI; Trotti, A | 1 |
| Kaji, H; Maiguma, T; Makino, K; Teshima, D | 1 |
| Annede, P; Blanchard, P; Bockel, S; Bourdis, M; Chargari, C; Deutsch, É; Drouet, M; François, S; Le Gallic, C; Lévy, A; Magné, N; Riccobono, D; Tao, Y; Vallard, A | 1 |
5 review(s) available for amifostine anhydrous and glutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cytoprotective agents used in the treatment of patients with cancer.
Topics: Amifostine; Antineoplastic Agents; Cytoprotection; Fibroblast Growth Factors; Glutamine; Humans; Mesna; Neoplasms; Razoxane | 2007 |
Emerging drugs for chemotherapy-induced mucositis.
Topics: Acetylcysteine; Amifostine; Antineoplastic Agents; Drugs, Investigational; Fibroblast Growth Factor 7; Glutamine; Humans; Mucositis; Palliative Care | 2008 |
Strategies for managing radiation-induced mucositis in head and neck cancer.
Topics: Acetylcysteine; Amifostine; Carcinoma, Squamous Cell; Glutamine; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Low-Level Light Therapy; Mouthwashes; Oral Hygiene; Pain Management; Risk Factors; Stomatitis | 2009 |
Pharmacological modulation of radiation-induced oral mucosal complications.
Topics: Amifostine; Analgesics; Anti-Inflammatory Agents; Benzydamine; Dietary Supplements; Fibroblast Growth Factor 7; Glutamine; Humans; Low-Level Light Therapy; Mouthwashes; Mucositis; Oral Hygiene; Radiation-Protective Agents; Radiotherapy; Risk Factors; Zinc | 2018 |
4 other study(ies) available for amifostine anhydrous and glutamine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Efficacy of radioprotective agents in preventing small and large bowel radiation injury.
Topics: Adenosine Triphosphate; Amifostine; Animals; Cysteine; Drug Therapy, Combination; Glutamine; Intestine, Large; Intestine, Small; Magnesium Chloride; Male; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines; Vitamin E | 1995 |
[Comments on five clinical trials concerning radiotherapy-induced mucositis in patients with head and neck neoplasms].
Topics: Amifostine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Glutamine; Granulocyte-Macrophage Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Pilot Projects; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Randomized Controlled Trials as Topic; Stomatitis; Sucralfate; Xerostomia | 2001 |
Protective effects of amifostine and cyclooxygenase-1 inhibitor against normal human epidermal keratinocyte toxicity induced by methotrexate and 5-fluorouracil.
Topics: Allopurinol; Amifostine; Antimetabolites, Antineoplastic; Calcium; Cell Line; Cell Proliferation; Cell Survival; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Fibroblasts; Fluorouracil; Free Radical Scavengers; Glutamine; Humans; Keratinocytes; Methotrexate; Periodontal Ligament; Protective Agents; Pyrazoles; Reactive Oxygen Species; Stomatitis | 2009 |